Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore approachable ways to celebrate budgeting milestones and sustain motivation. From small rewards to public acknowledgments, find methods that resonate with you.
12,829 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...
A 25 percent drop often triggers fear and temptation to buy the dip. This article breaks down IBM s recent results, t...
Canada and the United States push to accelerate trilateral trade talks after a surprise tariffs move, aiming to prote...
Investors are debating whether Palantir stock can still deliver. This guide breaks down the growth story, the risks, ...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
CAVA Group's shares jumped on expansion progress, signaling investor enthusiasm for growth. This article breaks down ...
OpenAI’s Sam Altman apologized for sloppy wording in announcing a Pentagon contract, pledging a revised release to em...
eXp Realty unveils a new division to help agents break into the new construction market. The program aims to close th...
Solana and XRP sit at the center of a debate about which blockchain will power the next wave of tokenized real-world ...
Traders eye a clearer long-run path for algorand as the network scales DeFi apps and CBDC pilots. This report outline...
A private AI-focused XR company invites retail investors to participate in a sub-$1 pre-IPO round, offering bonus sha...